From: Proceedings of Réanimation 2017, the French Intensive Care Society International Congress
Model 1 | Model 1 | Model 2 | Model 2 | |
---|---|---|---|---|
β | p | β | p | |
Age | −0.043 | <0.001 | −0.021 | <0.05 |
SOFA score | 0.071 | <0.001 | 0.103 | <0.001 |
Neuromuscular blocking agents (ref = no) | 0.450 | <0.001 | 0.336 | <0.05 |
Global end-diastolic volume (mL m−2) | 0.003 | <0.001 | – | – |
Dobutamine dose (µg kg min−1) | −0.021 | <0.01 | −0.023 | <0.01 |
PaCO2 (mmHg) | 0.014 | <0.01 | 0.013 | <0.05 |
PaO2/FiO2 (mmHg) | −0.002 | <0.001 | −0.001 | <0.05 |
PEEP (cm H2O) | NS | NS | −0.030 | <0.05 |
Time between ARDS onset and PP session | NS | NS | −0.044 | <0.05 |
Renal replacement therapy (ref = no) | NS | NS | −0.355 | <0.05 |
Measurement time [ref = before PP (T1)] | NS | NS | <0.001 | |
End of PP (T2) | 0 | |||
After PP (T3) | −0.204 |